Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.22 USD | -3.21% | -6.43% | -1.17% |
May. 08 | Earnings Flash (TSVT) 2SEVENTY BIO Reports Q1 Revenue $12.4M, vs. Street Est of $14.1M | MT |
May. 08 | Transcript : 2seventy bio, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Financials (USD)
Sales 2024 * | 48.62M | Sales 2025 * | 102M | Capitalization | 217M |
---|---|---|---|---|---|
Net income 2024 * | -142M | Net income 2025 * | -14M | EV / Sales 2024 * | 4.47 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.14 x |
P/E ratio 2024 * |
-1.54
x | P/E ratio 2025 * |
-9.98
x | Employees | 274 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.84% |
Latest transcript on 2seventy bio, Inc.
1 day | -3.21% | ||
1 week | -6.43% | ||
Current month | -0.24% | ||
1 month | -8.26% | ||
3 months | -25.18% | ||
6 months | +117.53% | ||
Current year | -1.17% |
Managers | Title | Age | Since |
---|---|---|---|
Chip Baird
CEO | Chief Executive Officer | 52 | - |
Nick Leschly
CHM | Chairman | 51 | 21-05-03 |
Susan Abu-Absi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Lynch
BRD | Director/Board Member | 65 | 21-10-14 |
Nick Leschly
CHM | Chairman | 51 | 21-05-03 |
Chip Baird
CEO | Chief Executive Officer | 52 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.23% | 2 M€ | -25.75% | ||
0.03% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 4.23 | -2.98% | 339,678 |
24-05-30 | 4.36 | +3.32% | 416,810 |
24-05-29 | 4.22 | -1.17% | 475,239 |
24-05-28 | 4.27 | -5.32% | 295,038 |
24-05-24 | 4.51 | +2.50% | 380,787 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.17% | 217M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- TSVT Stock